Question 1

JNJ vs RARE: which stock scores better overall?

Accepted Answer

Based on Q·Score, Johnson & Johnson (JNJ) scores 7.1/10 versus Ultragenyx Pharmaceutical Inc. (RARE) at 5.2/10. The Q·Score measures five dimensions: Quality, Value, Growth, Safety, and Momentum. For informational purposes only — not financial advice.

Question 2

Which has better revenue growth: JNJ or RARE?

Accepted Answer

Ultragenyx Pharmaceutical Inc. (RARE) scores higher on Growth (6.5/10 vs 5.1/10). Johnson & Johnson reports revenue growth (9.9% YoY) while Ultragenyx Pharmaceutical Inc. reports (25.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Question 3

Is JNJ or RARE more attractively valued?

Accepted Answer

Johnson & Johnson (JNJ) scores higher on Value (7.3/10 vs 6.9/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

Question 4

What do analysts say about JNJ vs RARE?

Accepted Answer

There are 24 analysts covering JNJ with a consensus price target of $252.42, and 20 analysts covering RARE with a consensus target of $53.35. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Question 5

Which is more profitable: JNJ or RARE?

Accepted Answer

Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 0.2/10). Net profit margin: JNJ at 21.8%, RARE at -85.4%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Question 6

Which has stronger financial health: JNJ or RARE?

Accepted Answer

Johnson & Johnson (JNJ) scores higher on Financial Health (6.5/10 vs 5.9/10). Market beta: JNJ at 0.33, RARE at 0.25. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

Question 7

What are the market caps of JNJ and RARE?

Accepted Answer

Johnson & Johnson (JNJ) has a market capitalisation of $546.9B, while Ultragenyx Pharmaceutical Inc. (RARE) has a market cap of $2.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Question 8

Do JNJ or RARE pay dividends?

Accepted Answer

JNJ pays a dividend yield of 2.36%, while RARE does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.

Johnson & Johnson vs Ultragenyx Pharmaceutical Inc. — Stock Comparison

Q·Score Breakdown

Analyst Consensus

Fundamentals